Benzodiazepine-like hypnotics and the associated risk of road traffic accidents

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 4, 2011, Pages 595-601

  Orriols, L ^a   Philip, P ^b   Moore, N ^c,d   Castot, A ^e   Gadegbeku, B ^f,g,h   Delorme, B ^e   Mallaret, M ⁱ   Lagarde, E ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL PELLEGRIN   (France)

^c INSERM U657   (France)

^d Centre of Clinical Investigation Clinical Epidemiology   (France)

^e AFSSAPS   (France)

^f University Lyon   (France)

^g UNIVERSITÉ DE LYON   (France)

^h UNIVERSITÉ LYON 1   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE; HYPNOTIC AGENT; LORMETAZEPAM; ZOLPIDEM; ZOPICLONE;

ACCIDENTAL INJURY; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; DISEASE SEVERITY; DRIVING ABILITY; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIOECONOMICS; TRAFFIC ACCIDENT;

EID: 79952990085     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.3     Document Type: Article

References (21)

1. Neutel, I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum. Psychopharmacol. Clin. Exp. 13, 115-123 (1998).
2. Neutel, C.I. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann. Epidemiol. 5, 239-244 (1995).
3. Gustavsen, I., Bramness, J.G., Skurtveit, S., Engeland, A., Neutel, I. & Mørland, J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, Zolpidem, Flunitrazepam and nitrazepam. Sleep Med. 9, 818-822 (2008).
4. Engeland, A., Skurtveit, S. & Mørland, J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann. Epidemiol. 17, 597-602 (2007). (Pubitemid 47096708)
5. Hemmelgarn, B., Suissa, S., Huang, A., Boivin, J.F. & Pinard, G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278, 27-31 (1997). (Pubitemid 27274512)
6. Vermeeren, A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18, 297-328 (2004). (Pubitemid 38526714)
7. Barbone, F. et al. Association of road-traffic accidents with benzodiazepine use. Lancet 352, 1331-1336 (1998). (Pubitemid 28510912)
8. Verster, J.C., Veldhuijzen, D.S. & Volkerts, E.R. Residual effects of sleep medication on driving ability. Sleep Med. Rev. 8, 309-325 (2004). (Pubitemid 38834209)
9. Laumon, B., Gadegbeku, B., Martin, J.L. & Biecheler, M.B.; SaM Group. Cannabis intoxication and fatal road crashes in France: population based case-control study. BMJ 331, 1371 (2005).
10. Noize, P. et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol. Drug Saf. 18, 310-319 (2009).
11. Philip, P., Vervialle, F., Le Breton, P., Taillard, J. & Horne, J.A. Fatigue, Alcohol, And serious road crashes in France: factorial study of national data. BMJ 322, 829-830 (2001). (Pubitemid 32291132)
12. Victorri-Vigneau, C., Dailly, E., Veyrac, G. & Jolliet, P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and information on pharmacodependence (CEip) network survey. Br. J. Clin. Pharmacol. 64, 198-209 (2007). (Pubitemid 47063241)
13. Drover, D.R. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, Zolpidem and zopiclone. Clin. Pharmacokinet. 43, 227-238 (2004). (Pubitemid 38429303)
14. Verster, J.C., Volkerts, E.R., Olivier, B., Johnson, W. & Liddicoat, L. Zolpidem and traffic safety -the importance of treatment compliance. Curr. Drug Saf. 2, 220-226 (2007). (Pubitemid 47591313)
15. Orriols, L. et al.; CESiR research group. Prescription medicines and the risk of road traffic crashes: a French registry-based study. PLoS Med. 7, E1000366 (2010).
16. Allain, H. & Monti, J. General safety profile of zolpidem: safety in elderly, Overdose and rebound effects. Eur. Psychiatry 12 (suppl. 1), 21-29 (1997).
17. Arrêté du 8 août 2008 pris pour l'application de l'article R. 5121-139 du code de la santé publique et relatif à l'apposition d'un pictogramme sur le conditionnement extérieur de certains médicaments et produits (8 august 2008).
18. Castot, A. & Delorme, B.; Medicinal products and Driving Working Group. Medicinal products and driving: how to assess the risk? P2t Congress Marseille 2009. Abstract no. 481.
19. Agence Française de Sécurité Sanitaire des produits de Santé. Medicinal products and Driving http://www.Afssaps.Fr/var/ afssaps-site/storage/ original/application/e5f2e48d5344bcfef6ca865ac63e7c3d.Pdf (March 2009).
20. Robertson, M.D. & Drummer, O.H. Responsibility analysis: a methodology to study the effects of drugs in driving. Accid. Anal. Prev. 26, 243-247 (1994). (Pubitemid 124006991)
21. Maclure, M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 133, 144-153 (1991).